HCA — HCA Healthcare, Inc. stock price, charts and financials

QT47HCA Healthcare, Inc.

HCA Healthcare, Inc. (NYSE: HCA) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
414.03
+0.67+0.16%
HCAQT47HCA Healthcare, Inc.·NYSE
414.03+0.16%
TA
Loading chart...
Screen all →
Snapshot
IndexS&P 500P/E13.80EPS (ttm)29.96Insider Own-Shs Outstand216.50MPerf Week2.68%
Market Cap89.49BForward P/E12.82EPS next Y32.23Insider Trans-0.01%Shs Float146.40MPerf Month1.06%
Enterprise Value137.26BPEG0.56EPS next Q6.78Inst Own-Short Float3.98%Perf Quarter-3.65%
Income6.65BP/S1.15EPS this Y-0.99%Inst Trans-Short Ratio3.66Perf Half Y-19.54%
Sales78.01BP/B-EPS next Y8.99%ROA11.30%Short Interest5.83MPerf YTD-11.46%
Book/sh-P/C8.28EPS next 5Y10.95%ROE-112.87%52W High557.39 -25.72%Perf Year12.89%
Cash/sh-P/FCF14.92EPS past 3/5Y14.01% 21.03%ROIC19.41%52W Low354.57 16.77%Perf 3Y53.44%
Dividend Est.3.12 (0.75%)EV/EBITDA8.67Sales past 3/5Y7.87% 7.97%Gross Margin28.36%Volatility2.80% 3.50%Perf 5Y66.54%
Dividend TTM3.00 (0.72%)EV/Sales1.76EPS Y/Y TTM35.77%Oper. Margin15.48%ATR (14)13.44Perf 10Y430.77%
Dividend Ex-DateSep 16, 2026Quick Ratio0.69Sales Y/Y TTM10.50%Profit Margin8.77%RSI (14)58.30Recom2.41
Dividend Gr. 3/5Y8.74% 46.28%Current Ratio0.78EPS Q/Q10.96%SMA205.75%Beta1.09Target Price455.19
Payout9.97%Debt/Eq-Sales Q/Q8.73%SMA506.40%Rel Volume0.61Prev Close413.36
Employees320,000LT Debt/Eq-15.68EarningsOct 23SMA200-9.53%Avg Volume1.69MPrice414.03
IPO DateMar 10, 2011Option/ShortYes / YesEPS/Sales Surpr.0.37% 2.40%Net Debt/EBITDA3.02Volume1,037,028Change0.16%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-28-26ReiteratedGoldman SachsBuy$520$485
Jul-27-26ReiteratedDeutsche BankBuy$540$476
Jul-27-26ReiteratedRobert W. Baird$396$393
Jul-27-26ReiteratedOppenheimerOutperform$520$485
Jul-27-26ReiteratedMorgan StanleyUnderweight$425$380
Jul-27-26ReiteratedUBSBuy$635$579
Jul-27-26ReiteratedBarclaysEqual Weight$402$387
Jul-27-26ReiteratedKeybancOverweight$510$435
Jul-20-26ReiteratedWells FargoEqual Weight$428$369
Jul-16-26ReiteratedBarclaysEqual Weight$427$402
Latest News
Aug-06-26
Aug-05-26
Aug-04-26
Aug-03-26
Jul-29-26
Jul-28-26
Jul-27-26
Jul-26-26
Jul-26-2602:02AM
Jul-24-26
Company

HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue78,01375,60070,603
Cost of Goods Sold Incl. D&A55,89244,22641,925
Gross Profit22,12131,37428,678
Selling, General and Administrative Excl. Other16,5737,99731,170
Research and Development
000
Other Operating Expense-6,52511,412-13,039
Operating Income12,07311,96510,547
Interest Expense2,3162,2482,061
Unusual Expense
Non-Operating Income (Expense)11411537
Net Income Before Taxes9,8719,8328,523
Income Taxes2,0182,0501,866
Consolidated Net Income6,8406,7845,760
Net Income From Continuing Operations7,8537,7826,657
Net Income6,8406,7845,760
EPS (Recurring)29.9628.6222.27
EPS (Basic, Before Extraordinaries)29.9628.6222.27
EPS (Diluted)29.8728.3822.00
EBITDA15,83515,60313,896
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio13.8616.4513.64
Price To Sales Ratio1.181.431.10
Gross Margin28.3641.5040.62
Operating Margin15.4815.8314.94
Net Margin8.778.978.16
Shares Outstanding223231259
Market Capitalization92,329107,84577,739
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$576.75$508.24$439.72$371.21$302.70 Close Price0.00M7.32M14.64M21.96M29.28MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
McAlevey Michael REVP & Chief Legal & Admin Off.Feb 18 '26Sale533.371,694903,5378,853Feb 18
McAlevey Michael REVP & Chief Legal & Admin Off.Feb 13 '26Option Exercise236.615,0001,183,05013,853Feb 18
Berres JenniferSVP & Chief Human Res. OfficerFeb 11 '26Sale514.588,0204,126,95011,993Feb 12
Wyatt Christopher F.SVP & ControllerFeb 11 '26Sale505.004,0002,020,00044,379Feb 12
Wyatt Christopher F.SVP & ControllerFeb 05 '26Option Exercise139.0610,6701,483,77051,737Feb 09
Foster Jon MEVP and COOFeb 05 '26Option Exercise139.0629,3304,078,63029,330Feb 09
HAZEN SAMUEL NCEOFeb 03 '26Sale501.0442,87721,483,27532,276Feb 05
Cuffe Michael S.EVP and Chief Clinical OfficerFeb 03 '26Sale498.091,500747,13530,003Feb 05
HAZEN SAMUEL NCEOJan 30 '26Option Exercise81.9684,3606,914,146116,636Feb 02
McAlevey Michael REVP & Chief Legal & Admin Off.Nov 05 '25Sale473.793,8921,843,9913,487Nov 05
McAlevey Michael REVP & Chief Legal & Admin Off.Nov 03 '25Option Exercise236.6113,1703,116,15416,657Nov 05
HAZEN SAMUEL NCEOOct 31 '25Option Exercise69.5858,0504,039,11975,279Nov 04
Cuffe Michael S.EVP and Chief Clinical OfficerSep 08 '25Sale418.843,8361,606,67031,503Sep 08
Cuffe Michael S.EVP and Chief Clinical OfficerSep 04 '25Option Exercise173.1210,9201,890,47042,423Sep 08
Foster Jon MEVP and COOMay 13 '25Sale369.3215,6985,797,66112,646May 15
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.